News Seventeen million euros for Netherlands X omics Initiative

13 April 2018

The Netherlands X-omics Initiative, led by Radboud university medical center, has received 17 million euros from the Netherlands Organisation for Scientific Research (NOW) as part of the National Roadmap for Large-Scale Research Facilities. The X-omics Initiative is one of ten projects awarded by Minister of Education, Culture and Science Ingrid van Engelshoven. A total of 138 million euros has been allocated to facilitate a large-scale research infrastructure in the Netherlands.

In recent years we have seen a spectacular growth of research into genomics, proteomics, metabolomics as well as bioinformatics. The awarding of this X-omics Initiative [pronounced ‘cross-omics’] has given an extra quality incentive to the research structure built up in the Netherlands around genomics (Edwin Cuppen, University Medical Center Utrecht), proteomics (Albert Heck, Utrecht University), metabolomics (Thomas Hankemeier, Leiden University) and integration of data (Alain van Gool, Radboud university medical center).
 
Cells in action
Coordinator Alain van Gool: “Our objective is to increase the technological possibilities of all these -omics techniques to a high extent. Also, the higher level of data integration will allow us to map the dynamics among the various -omics levels. As yet, analyses of genomics, proteomics and metabolomics are often separate approaches, hardly connecting with each other. With the X-omics Initiative we are now able to integrate all available data on all levels and to use these data for complex, dynamic analyses of the way in which cells and tissues function as a system. Our newly acquired knowledge of these molecular building blocks of life will allow us to see the contours of cells and tissues in action.”
 
Demonstration projects
Combining and improving -omics techniques will contribute to more knowledge of the fundamentals of health and disease, for example regarding cancer, immunoreactions, unique rare diseases and the effect of genetic variations among the Dutch population. The Initiative will set up demonstration projects on various levels to illustrate the power of the -omics techniques in these fields. Hans Clevers and Rene Bernards will study cells and organoids for drugs to cure cancer and the development of resistance to these drugs. Mihai Netea and Han Brunner (both from Radboud university medical center) will study individual patients to look for individual differences regarding rare diseases, while Cornelia van Duijn (Erasmus University Medical Center) and Cisca Wijmenga (University Medical Center Groningen) will analyze population-based genetic variations among the Dutch population.
 
National X-omics Infrastructure
Van Gool explicitly states that the X-omics Initiative is a national initiative: “The added value of this initiative lies to a large extent in the cooperation of the top institutes that are already involved in all these -omics parts and data integration. This is the only way to really make a giant leap forward. We have to make this effort together to achieve that, and we commit ourselves to taking the lead in this field worldwide.”
­­­­­­­­­­­­-
Zie ook: www.x-omics.nl
Roadmap-subsidies: Ruim 27 miljoen euro naar Radboud-onderzoeksfaciliteiten
www.nwo.nl/actueel/nieuws/2018/04/nationale-roadmap-138-miljoen-voor-tien-hoogwaardige-onderzoeksfaciliteiten.html
www.nwo.nl/documents/nwo/programmas/gehonoreerde-aanvragen-roadmap-2017-2018
The National Roadmap for Large-Scale Research Facilities encourages setting up or improving large research facilities, enabling the Netherlands to take up an important position in the international research field.
The objective of the National Roadmap for Large-Scale Research Facilities is to invest in Dutch research facilities with an international reputation or in Dutch involvement in building or adapting international research facilities.

Related news items


3 DCMN researchers among most cited scientists

10 December 2018

Christian Beckmann, Jan Buitelaar and Barbara Franke made it to this year’s list of highly cited researchers. Scientists in this list are selected for their exceptional research performance and are regarded to have had a major impact on fellow scientists.

read more

Discover Israels' secret to startup success

6 December 2018

International exchange of staff is an indispensable part of one’s personal and professional growth. In the context of entrepreneurship, exciting career opportunities and networking an educational and inspiring trip to Israel is planned. You are invited to join for free (only for PhD's).

read more

René Vogels Stichting travel grant for Pieter Roelofs

4 December 2018

Pieter Roelofs received the award in order to perform a work visit to prof. Reuben Harris’ lab at the University of Minnesota, USA.

read more

Symposium on inclusive research Monday 14 January 2019

4 December 2018

How does inclusive research with people with intellectual disabilities work? The academic collaborative ‘Sterker op eigen benen’ invites you to this free symposium ‘Inclusief onderzoek in ‘t eggie’ followed by the PhD defense of Tessa Frankena.

read more

MRI improves detection of prostate cancer Prostate biopsy no longer necessary for 50% of male patients

4 December 2018

There is good news for the more than 40,000 men per year who go to the hospital for diagnosis because of elevated Prostate-Specific Antigen (PSA) levels. “Thanks to the use of MRI, we can reduce the number of prostate biopsies by half,” says Jelle Barentsz.

read more

European Reference Networks illustrative video

30 November 2018

Watch here a moving video about the ERN for rare epilepsies which explains what the ERNs do.

read more
  • Go to